Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37505

ANKRD28 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The ANKRD28 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from HeLa cells, a widely used human cervical adenocarcinoma line. This loss-of-function model targets ANKRD28, a regulatory subunit of the PP6 phosphatase complex that controls mitotic progression and DNA damage repair through dephosphorylation of substrates like AURKA and ATM. These cells provide a valuable tool for investigating PP6-dependent signaling, focal adhesion dynamics, and cancer cell biology. Applications include Western blotting for phosphorylated AURKA, immunofluorescence for mitotic defects, and cell migration assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    ANKRD28

    Gene Identifier

    NCBI Gene ID 23243

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANKRD28 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed for disruption of the ANKRD28 gene in a widely used human cervical epithelial adenocarcinoma line. This loss-of-function model provides a versatile platform for investigating the functional roles of the ANKRD28 regulatory subunit of protein phosphatase 6 (PP6). The polyclonal nature of these knockout cells ensures genetic heterogeneity, avoiding clonal artifacts and enabling robust population-level studies of gene function in cancer-relevant contexts.

The host cell line, HeLa, is derived from a human cervical adenocarcinoma and is immortalized with HPV-18 integration. These cells exhibit adherent epithelial morphology and are extensively characterized in cancer research, offering reliable growth kinetics and established protocols for protein expression, signal transduction, and cytotoxic assays. Their genetic background retains key oncogenic drivers, making them particularly suitable for dissecting signaling pathways that intersect with viral oncoproteins and cellular transformation.

ANKRD28 encodes a scaffold subunit of the PP6 holoenzyme that, together with PPP6C, ANKRD44, and ANKRD52, forms a complex activated by upstream kinases CDK1 and PLK1. This phosphatase module dephosphorylates critical substrates including AURKA, NCAPD2, PRKDC, and ATM, thereby coordinating mitotic exit, DNA damage checkpoint recovery, and genome stability. Additionally, ANKRD28 interacts with 14-3-3 proteins at focal adhesions, linking PP6 activity to cytoskeletal reorganization and cell migration. Disruption of ANKRD28 thus impairs multiple PP6-dependent signaling nodes.

In HeLa cells, which harbor active PP6 signaling and HPV-18-driven proliferative programs, ANKRD28 knockout provides a physiologically relevant model to study how PP6 regulatory subunits influence cancer cell phenotypes. This system is particularly valuable for examining the crosstalk between DNA damage repair pathways and mitotic fidelity in a cervical adenocarcinoma context. The transformed nature of HeLa cells amplifies the observable consequences of ANKRD28 loss on proliferation, migration, and stress responses.

Researchers can utilize these knockout cells in Western blotting to monitor changes in AURKA phosphorylation, immunofluorescence to visualize mitotic spindle abnormalities, and gamma-H2AX staining to assess DNA damage accumulation. Co-immunoprecipitation experiments can probe altered PPP6C complex formation, while migration assays provide insight into focal adhesion dynamics. These applications make the cells a powerful tool for mechanistic studies in cancer cell biology, DNA damage response, and PP6-related signaling. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)